Dasatinib reduces myelofibrosis by modulating pSTAT5 and NF-κB.
Schelker RC, Andrulis M, Müller G, Ushmorov A, Hart C, Herr W, Vogelhuber M, Iberl S, Grassinger J.
Schelker RC, et al.
Blood Cells Mol Dis. 2019 May;76:78-81. doi: 10.1016/j.bcmd.2019.02.005. Epub 2019 Feb 20.
Blood Cells Mol Dis. 2019.
PMID: 30827761
No abstract available.